Pathogenicity of Toxoplasma gondii through B-2 cell-mediated downregulation of host defense responses

Microbiology and Immunology

Volumn 47, Issue 7, 2003, Pages 533-542

  Mun, Hye Seong ^a   Aosai, Fumie ^a   Chen, Mei ^a   Piao, Lian Xun ^a   Norose, Kazumi ^a   Iwakura, Yoichiro ^b   Yano, Akihiko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

B lymphocytes; Cytokine; Nitric oxide; Toxoplasma gondii

Indexed keywords

CD11B ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 4; NITRIC OXIDE; STAT1 PROTEIN;

ADOLESCENT; ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B1A LYMPHOCYTE; B2 LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IRRADIATION; KNOCKOUT MOUSE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PATHOGENICITY; PERITONEUM EXUDATE; PROTEIN PHOSPHORYLATION; SUPPRESSOR CELL; SURVIVAL; T LYMPHOCYTE; TOXOPLASMA GONDII; TOXOPLASMOSIS; TOXOPLASMOSIS GONDII FUKAYA STRAIN;

ANIMALIA; PROTOZOA; TOXOPLASMA GONDII;

EID: 0042311279     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb03415.x     Document Type: Article

References (57)

1. Alexander, J., Jebbari, H., Bluethmann, H., Brombacher, F., and Roberts, C.W. 1998. The role of IL-4 in adult acquired and congenital toxoplasmosis. Int. J. Parasitol. 28: 113-120.
2. Anderson, S.E., Krahenbuhl, J.L., Jr., and Remington, J.S. 1979. Longitudinal studies of lymphocyte response to toxoplasma antigens in humans infected with T. gondii. J. Clin. Lab. Immunol. 2: 293-297.
3. Aosai, F., Mun, H.S., Norose, K., Chen, M., Hata, H., Kobayashi, M., Kiuchi, M., Stauss, H.J., and Yano, A. 1999. Protective immunity induced by vaccination with SAGI gene-transfected cells against Toxoplasma gondii-infection in mice. Microbiol. Immunol. 43: 87-91.
4. Aosai, F., Yang, T.H., Ueda, M., and Yano, A. 1994. Isolation of naturally processed peptides from a Toxoplasma gondii-infected human B lymphoma cell line that are recognized by cytotoxic T lymphocytes. J. Parasitol. 80: 260-266.
5. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2: 907-916.
6. Channon, J.Y., and Kasper, L.H. 1996. Toxoplasma gondii-induced immune suppression by human peripheral blood monocytes: role of gamma interferon. Infect. Immun. 64: 1181-1189.
7. Chaves, A.C., Ceravolo, I.P., Gomes, J.A., Zani, C.L., Romanha, A.J., and Gazzinelli, R.T. 2001. IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-gamma. Eur. J. Immunol. 31: 333-344.
8. Chen, M., Aosai, F., Mun, H.S., Norose, K., Hata, H., and Yano, A. 2000. Anti-HSP70 autoantibody formation by B- I cells in Toxoplasma gondii-infected mice. Infect. Immun. 68: 4893-4899.
9. Chen, M., Aosai, F., Norose, K., Mun, H.S., and Yano, A. 2003. The role of anti-HSP70 autoantibody-forming V(H)1-J(H)1 B-1 cells in Toxoplasma gondii-infected mice. Int. Immunol. 15: 39-47.
10. Coccia, E.M., Stellacci, E., Marziali, G., Weiss, G., and Battistini, A. 2000. IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. Int. Immunol. 12: 977-985.
11. Flano, E., Husain, S.M., Sample, J.T., Woodland, D.L., and Blackman, M.A. 2000. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165: 1074.
12. Fujita, T., Reis, L.F., Watanabe, N., Kimura, Y., Taniguchi, T., and Vilcek, J. 1989. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. U.S.A. 86: 9936-9940.
13. Halonen, S.K., and Weiss, L.M. 2000. Investigation into the mechanism of gamma interferon-mediated inhibition of Toxoplasma gondii in murine astrocytes. Infect. Immun. 68: 3426-3430.
14. Hardy, R.R., and Hayakawa, K. 1994. CD5 B cells, a fetal B cell lineage. Adv. Immunol. 55: 297-339.
15. He, N., Aosai, F., Mun, H.S., Sekiya, S., and Yano, A. 1997. Cytokine production assayed by RT-PCR in pregnant mice infected by Toxoplasma gondii as a model of congenital toxoplasmosis. Jpn. J. Trop. Med. Hyg. 25: 59-67.
16. Jones, T.C., Alkan, S., and Erb, P. 1986. Spleen and lymph node cell populations, in vitro cell proliferation and interferon-γ production during primary immune response to Toxoplasma gondii. Parasite Immunol. 8: 619-629.
17. Kang, H., Remington, J.S., and Suzuki, Y. 2000. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase. J. Immunol. 164: 2629-2634.
18. Kang, H., and Suzuki, Y. 2000. Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain. Infect. Immun. 69: 2920-2927.
19. -/- mice. J. Immunol. 156: 636-643.
20. Khan, I.A., Smith, K.A., and Kasper, L.H. 1988. Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J. Immunol. 141: 3600-3605.
21. Kobayashi, M., Aosai, F., Hata, H., Mun, H.S., Tagawa, Y., Iwakura, Y., and Yano, A. 1999. Toxoplasma gondii: difference of invasion into tissue of digestive organs between susceptible and resistant strain and influence of IFN-γ in mice inoculated with the cysts perorally. J. Parasitol. 85: 973-975.
22. Luft, B.J., Kansas, G., Engleman, E.G., and Remington, J.S. 1984. Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis. J. Infect. Dis. 150: 761-767.
23. Luft, B.J., Pedrotti, P.W., and Remington, J.S. 1988. In vitro generation of adherent mononuclear suppressor cells to Toxoplasma antigen. Immunology 63: 643-648.
24. Luo, W., Aosai, F., Ueda, M., Yamashita, K., Shimizu, K., Sekiya, S., and Yano, A. 1997. Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR. J. Parasitol. 83: 1070-1074.
25. Mason, P.R., and Gwanzura, L. 1990. Reduced lymphocyte responses to mitogens in natural and experimental trichomoniasis. Infect. Immun. 58: 3553-3557.
26. McCabe, R.E., Luft, B.J., and Remington, J.S. 1984. Effect of murine interferon gamma on murine toxoplasmosis. J. Infect. Dis. 150: 961-962.
27. McLeod, R., Beem, M.O., and Estes, R.G. 1985. Lymphocyte anergy specific to Toxoplasma gondii antigens in a baby with congenital toxoplasmosis. J. Clin. Lab. Immunol. 17: 149-153.
28. Molloy, A., Laochumroonvorapong, P., and Kaplan, G. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J. Exp. Med. 180: 1499-1509.
29. + T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells. Infect. Immun. 64: 176-181.
30. Mun, H.S., Aosai, F., Norose, K., Chen, M., Hata, H., Tagawa, Y.I., Iwakura, Y., Byun, D.S., and Yano, A. 2000. Toxoplasma gondii Hsp70 as a danger signal in Toxoplasma gondii-infected mice. Cell Stress Chaperones 5: 328-335.
31. Mun, H.S., Aosai, F., and Yano, A. 1999. Role of Toxoplasma gondii HSP70 and Toxoplasma gondii HSP30/bag 1 in antibody formation and prophylactic immunity in mice experimentally infected with Toxoplasma gondii. Microbiol. Immunol. 43: 471-479.
32. Mun, H.S., Norose, K., Aosai, F., Chen, M., and Yano, A. 2000. A role of carboxy-terminal region of Toxoplasma gondii-heat shock protein 70 in enhancement of T. gondii infection in mice. Korean J. Parasitol. 38: 107-110.
33. Nathan, C.F., Murray, H.W., Wiebe, M.E., and Rubin, B.Y. 1983. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158: 670-689.
34. Neyer, L.E., Grunig, G., Fort, M., Remington, J.S., Rennick, D., and Hunter, C.A. 1997. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65: 1675-1682.
35. Norose, K., Mun, H.S., Aosai, F., Chen, M., Hata, H., Tagawa, Y., Iwakura, Y., and Yano, A. 2001. Organ infectivity of Toxoplasma gondii in interferon-gamma knockout mice. J. Parasitol. 87: 447-452.
36. Ohmori, Y., and Hamilton, T.A. 1997. IL-4-induced STAT6 suppresses IFN-gamma-stimulated STAT1-dependent transcription in mouse macrophages. J. Immunol. 159: 5474-5482.
37. Paludan, S.R., Ellermann-Eriksen, S., Lovmand, J., and Mogensen, S.C. 1999. Interleukin-4-mediated inhibition of nitric oxide production in interferon-gamma-treated and virus-infected macrophages. Scand. J. Immunol. 49: 169-176.
38. Rohrer, J.W., Culpepper, C., Barsoum, A.L., and Coggin, J.H., Jr. 1995. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning. J. Immunol. 154: 2266-2280.
39. Rutschman, R., Lang, R., Hesse, M., Ihle, J.N., Wynn, T.A., and Murray, P.J. 2001. Stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 166: 2173-2177.
40. Saito, S., Aosai, F., Rikihisa, N., Mun, H.S., Norose, K., Chen, M., Kuroki, T., Asano, T., Ochiai, T., and Yano, A. 2001. Establishment of gene-vaccinated skin grafting against Toxoplasma gondii infection in mice. Vaccine 19: 2172-2180.
41. Scharton-Kersten, T.M., Yap, G., Magram, J., and Sher, A. 1997. Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J. Exp. Med. 185: 1261-1273.
42. Stenger, S., Mazzaccaro, R.J., Uyemura, K., Cho, S., Barnes, P.F., Rosat, J.P., Sette, A., Brenner, M.B., Porcelli, S.A., and Modlin, R.L. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276: 1684-1687.
43. Strickland, G.T., Ahmed, A., and Sell, K.W. 1975. Blastogenic response of Toxoplasma-infected mouse spleen cells to T- and B-cell mitogens. Clin. Exp. Immunol. 22: 167-176.
44. Suzuki, Y., Joh, K., and Kobayashi, A. 1987. Macrophage-mediated suppression of immune responses in Toxoplasma-infected mice. III. Suppression of antibody responses to parasite itself. Cell. Immunol. 110: 218-225.
45. Suzuki, Y., Orellana, M.A., Schreiber, R.D., and Remington, J.S. 1988. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
46. + T cells in mice. J. Immunol. 140: 3943-3946.
47. Suzuki, Y., Watanabe, N., and Kobayashi, A. 1981. Non-specific suppression of initiation of memory cells in Toxoplasma gondii-infected mice. Infect. Immun. 34: 36-42.
48. Suzuki, Y., Yang, Q., Yang, S., Nguyen, N., Lim, S., Liesenfeld, O., Kojima, T., and Remington, J.S. 1996. IL-4 is protective against development of toxoplasmic encephalitis. J. Immunol. 157: 2564-2569.
49. Swierczynski, B., Bessieres, M.H., Cassaing, S., Guy, S., Oswald, I., Seguela, J.P., and Pipy, B. 2000. Inhibitory activity of anti-interleukin-4 and anti-interleukin-10 antibodies on Toxoplasma gondii proliferation in mouse peritoneal macrophages cocultured with splenocytes from infected mice. Parasitol. Res. 86: 151-157.
50. Tagawa, Y., Sekikawa, K., and Iwakura, Y. 1997. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J. Immunol. 159: 1418-1428.
51. Thouvenin, M., Candolfi, E., Villard, O., Klein, J.P., and Kien, T. 1997. Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are type 2-dependent. Parassitologia 39: 279-283.
52. Villard, O., Candolfi, E., Despringre, J.L., Derouin, F., Marcellin, L., Viville, S., and Kien, T. 1995. Protective effect of low doses of an anti-IL-4 monoclonal antibody in a murine model of acute toxoplasmosis. Parasite Immunol. 17: 233-236.
53. Watanabe, N., and Kobayashi, A. 1989. Regulation of immunoglobulin E production in mice immunized with an extract of Toxoplasma gondii. Infect. Immun. 57: 1405-1408.
54. Yamashita, K., Yui, K., Ueda, M., and Yano, A. 1998. Cytotoxic T-lymphocyte-mediated lysis of Toxoplasma gondii-infected target cells does not lead to death of intracellular parasites. Infect. Immun. 66: 4651-4655.
55. - cytotoxic T lymphocytes specific for T. gondii-infected human melanoma cells. J. Immunol. 154: 290-298.
56. + cytotoxic cells. J. Parasitol. 75: 411-416.
57. Yano, A., Norose, K., Yamashita, K., Aosai, F., Sugane, K., Segawa, K., and Hayashi, S. 1987. Immune response to Toxoplasma gondii - analysis of suppressor T cells in a patient with symptomatic acute toxoplasmosis. J. Parasitol. 73: 954-961.